Publications

研究業績

創薬・診断技術と研究開発

Strategic manufacturing and versatile applications to expand the mRNA therapeutic frontier

Masashi Abe; Yuri Sano-Fujimoto; Yu Nishida; Kota Kodama; Shuto Miyashita; Shintaro Sengoku
Drug Discovery Today. 2026; 31(5): 104774.
https://doi.org/10.1016/j.drudis.2026.104774

創薬・診断技術と研究開発

Evolution of the division of labor for First-in-Class Drugs: A Quantitative Analysis of Trends across Company Types, Modalities, and Therapeutic Areas (2012–2024)

Yusuke Izumiya; Yoshiyuki Kobayashi; Itsuki Kageyama; Shintaro Sengoku; Kota Kodama
Drug Discovery Today. 2026; 31(3): 104669.
https://doi.org/10.1016/j.drudis.2026.104669

創薬・診断技術と研究開発

Advancing ex vivo gene therapy: the role of lentiviral vectors and organizational collaboration

Yuri Sano-Fujimoto; Yu Nishida; Kota Kodama; Shuto Miyashita; Shintaro Sengoku
Drug Discovery Today. 2025; 30(12): 104510.
https://doi.org/10.1016/j.drudis.2025.104510

創薬・診断技術と研究開発

Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins

Makoto Niwa; Kenta Noda; Yoshiyuki Kobayashi; Itsuki Kageyama; Kota Kodama
Bioanalysis. 2025; 17(10): 671–680.
https://doi.org/10.1080/17576180.2025.2515011

創薬・診断技術と研究開発

Multi-layer platform coordination for open innovation in oligonucleotide therapeutics

Yayoi Kawata; Taisuke Ichimaru; Masakazu Kogami; Kota Kodama; Shuto Miyashita; Shintaro Sengoku
Drug Discovery Today. 2025; 30(2): 104288.
https://doi.org/10.1016/j.drudis.2025.104288

博士課程への入学をご検討の方へ

FAQ・指導体制の詳細をご確認いただけます

博士課程募集要項を見る

博士課程募集要項を見る